A3adenosine receptor activation decreases mortality and renal and hepatic injury in murine septic peritonitis

H. Thomas Lee1, Mihwa Kim, Jin Deok Joo, George Gallos, Jiang‐Fan Chen, Charles W. Emala
1Department of Anesthesiology, Anesthesiology Research Laboratories, Columbia University, P&S Box 46 (PH-5 630 West 168th St., New York, NY 10032-3784, USA. [email protected]

Tóm tắt

The role of A3adenosine receptors (ARs) in sepsis and inflammation is controversial. In this study, we determined the effects of A3AR modulation on mortality and hepatic and renal dysfunction in a murine model of sepsis. To induce sepsis, congenic A3AR knockout mice (A3AR KO) and wild-type control (A3AR WT) mice were subjected to cecal ligation and double puncture (CLP). A3AR KO mice had significantly worse 7-day survival compared with A3AR WT mice. A3AR KO mice also demonstrated significantly higher elevations in plasma creatinine, alanine aminotransferase, aspartate aminotransferase, keratinocyte-derived chemokine, and TNF-α 24 h after induction of sepsis compared with A3AR WT mice. Renal cortices from septic A3AR KO mice exhibited increased mRNA encoding proinflammatory cytokines and enhanced nuclear translocation of NF-kB compared with samples from A3AR WT mice. A3AR WT mice treated with N6-(3-iodobenzyl)ADO-5′ N-methyluronamide (IB-MECA; a selective A3AR agonist) or 3-ethyl-5-benzyl-2-methyl-4-phenylethynyl-6-phenyl-1,4-(±)-dihydropyridine-3,5-dicarboxylate (MRS-1191; a selective A3AR antagonist) had improved or worsened 7-day survival after induction of sepsis, respectively. Moreover, A3AR WT mice treated with IB-MECA or MRS-1191 showed acutely improved or worsened, respectively, renal and hepatic function following CLP. IB-MECA significantly reduced mortality in mice lacking the A1AR or A2aAR but not the A3AR, demonstrating specificity of IB-MECA in activating A3ARs and mediating protection against sepsis-induced mortality. We conclude that endogenous or exogenous A3AR activation confers significant protection from murine septic peritonitis primarily by attenuating the hyperacute inflammatory response in sepsis.

Từ khóa


Tài liệu tham khảo

10.1152/ajpregu.00373.2001

10.1097/00024382-200014020-00001

10.1097/00003246-200107001-00035

10.1097/01.shk.0000180621.52058.e1

10.1128/IAI.68.4.1942-1945.2000

10.1056/NEJM199704103361506

10.1523/JNEUROSCI.19-21-09192.1999

10.1164/rccm.200109-014OC

10.1152/ajpgi.00348.2003

10.1097/01.shk.0000144134.03598.c5

10.1177/039139880402700503

10.1152/ajpregu.00678.2005

10.1152/ajpgi.00338.2005

Firestein GS, Boyle D, Bullough DA, Gruber HE, Sajjadi FG, Montag A, Sambol B, and Mullane KM.Protective effect of an adenosine kinase inhibitor in septic shock.J Immunol152: 5853–5859, 1994.

10.1016/0014-2999(95)00822-5

10.1097/00000542-200410000-00015

10.1152/ajprenal.00470.2004

Guo RF, Riedemann NC, and Ward PA.Role of C5a-C5aR interaction in sepsis.Shock21: 1–7, 2004.

10.1016/S0014-2999(98)00619-0

Hasko G, Szabo C, Nemeth ZH, Kvetan V, Pastores SM, and Vizi ES.Adenosine receptor agonists differentially regulate IL-10, TNF-alpha, and nitric oxide production in RAW 264.7 macrophages and in endotoxemic mice.J Immunol157: 4634–4640, 1996.

10.1016/0009-8981(73)90466-X

10.1097/01.CCM.0000129488.54282.1A

10.1056/NEJMra021333

10.1080/00365540310015692

10.1016/S0165-6147(98)01203-6

10.1152/jappl.1995.78.3.990

10.1128/IAI.70.8.4441-4446.2002

10.1152/ajprenal.2000.278.3.F380

10.1097/01.ASN.0000102474.68613.AE

10.1152/ajprenal.00271.2002

10.1152/ajprenal.00185.2003

10.1016/S0014-2999(03)01570-X

Manley MO, O’Riordan MA, Levine AD, and Latifi SQ.Interleukin 10 extends the effectiveness of standard therapy during late sepsis with serum interleukin 6 levels predicting outcome.Shock23: 521–526, 2005.

10.1056/NEJMoa022139

10.1124/mol.104.005926

10.1016/j.cyto.2004.12.019

10.1016/0014-2999(96)00272-5

10.4049/jimmunol.176.9.5616

10.1152/ajprenal.2000.279.5.F809

10.1152/ajprenal.1999.277.3.F404

Parmely MJ, Zhou WW, Edwards CK III, Borcherding DR, Silverstein R, and Morrison DC.Adenosine and a related carbocyclic nucleoside analogue selectively inhibit tumor necrosis factor-alpha production and protect mice against endotoxin challenge.J Immunol151: 389–396, 1993.

10.1002/hep.510290104

10.1007/s000110050169

10.1097/00024382-199508000-00002

10.1128/IAI.73.5.2751-2757.2005

10.1074/jbc.275.6.4429

10.1016/j.plefa.2005.07.008

10.1086/386311

10.1086/386311

10.1073/pnas.171317998

10.1172/JCI8253

10.4049/jimmunol.173.2.1380

10.1093/ndt/15.10.1562